MEDICAL POLICY SUBJECT: PHOTOTHERAPY FOR THE TREATMENT OF SEASONAL AFFECTIVE DISORDER. POLICY NUMBER: CATEGORY: Behavioral Health

Similar documents
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation

MEDICAL POLICY SUBJECT: MAMMOGRAPHY: COMPUTER- AIDED DETECTION (CAD) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY EFFECTIVE DATE: 04/28/11 REVISED DATE: 04/26/12, 04/25/13, 04/24/14, 06/25/15, 06/22/16, 06/22/17

Supplementary Online Content

Seasonal Affective Disorder

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES. Page: 1 of 5. Medical Policy Title CRANIAL ORTHOTICS Policy Number 1.01.

Bright Light Therapy: A Non-Drug Way to Treat Depression and Sleep Problems

MEDICAL POLICY SUBJECT: TUMOR CHEMORESISTANCE AND CHEMOSENSITIVITY ASSAYS. POLICY NUMBER: CATEGORY: Laboratory Test

Seasonal Affect Disorder (SAD) By, Leah Wasicka

UC San Diego UC San Diego Previously Published Works

Drug Surveillance 1.

MEDICAL POLICY SUBJECT: AUTOMATED AMBULATORY BLOOD PRESSURE MONITORING

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

MEDICAL POLICY SUBJECT: PSYCHOLOGICAL TESTING. POLICY NUMBER: CATEGORY: Behavioral Health

MEDICAL POLICY SUBJECT: TRANSMYOCARDIAL REVASCULARIZATION

MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND (TRUS)

MEDICAL POLICY SUBJECT: MAGNETIC ESOPHAGEAL RING/ MAGNETIC SPHINCTER AUGMENTATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD)

MEDICAL POLICY EFFECTIVE DATE: 08/21/14 REVISED DATE: 04/16/15, 06/16/16, 07/20/17 SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

MOTION DIAGNOSTIC IMAGING (CMDI)/ GAIT ANALYSIS

MEDICAL POLICY SUBJECT: NUTRITIONAL THERAPY

MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: COCHLEAR IMPLANTS AND AUDITORY BRAINSTEM IMPLANTS. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR BLADDER CANCER. POLICY NUMBER: CATEGORY: Technology Assessment

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

MEDICAL POLICY SUBJECT: HOME PROTHROMBIN TIME MONITORING DEVICE. POLICY NUMBER: CATEGORY: Equipment/Supplies

MEDICAL POLICY SUBJECT: RADIOFREQUENCY JOINT ABLATION / DENERVATION

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Corporate Medical Policy

MEDICAL POLICY SUBJECT: COMPUTER ASSISTED NAVIGATION FOR KNEE AND HIP ARTHROPLASTY

MEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS

MEDICAL POLICY SUBJECT: FEMALE STERILIZATION. POLICY NUMBER: CATEGORY: Contract Clarification

MEDICAL POLICY SUBJECT: ENHANCED EXTERNAL COUNTERPULSATION

Light Therapy in Sleep Disorders 2014

MEDICAL POLICY SUBJECT: NUTRITIONAL THERAPY. POLICY NUMBER: CATEGORY: Therapy/Rehabilitation

MEDICAL POLICY SUBJECT: BULKING AGENTS FOR TREATMENT OF URINARY OR FECAL INCONTINENCE. POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: CHELATION THERAPY. POLICY NUMBER: CATEGORY: Technology Assessment

Research Article Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine

MEDICAL POLICY EFFECTIVE DATE: 12/18/08 REVISED DATE: 12/17/09, 03/17/11, 05/19/11, 05/24/12, 05/23/13, 05/22/14

MEDICAL POLICY SUBJECT: GENOTYPING OR PHENOTYPING FOR THIOPURINE METHYLTRANSFERASE (TPMT) FOR PATIENTS TREATED WITH AZATHIOPRINE (6-MP)

MEDICAL POLICY. SUBJECT: ISOLATED LIMB PERFUSION and INFUSION

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION

MEDICAL POLICY SUBJECT: OCCUPATIONAL THERAPY (OT) POLICY NUMBER: CATEGORY: Therapy/Rehabilitation

Clinical Policy Title: Pharmacogenomic tests for psychiatric medications

Corporate Medical Policy

Seasonal Affective Disorder

Measurement of Mental Health among Adolescents at the Population Level (MMAP) Conceptual Framework and Roadmap

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES. Page: 1 of 5

III. Based upon our criteria and review of the peer-reviewed literature, NMES has not been proven to be effective and is

tens_(transcutaneous_electrical_nerve_stimulator) 7/ / / /2014 This policy is NOT effective until January 13, 2015

MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING

Psychiatry Clinical Reviews Depression What Matters and Why?

Biofeedback as a Treatment of Headache

Medical Policy Title GENOTYPING URIDINE DIPHOSPHATE GLYCURONOSYLTRANSFERASE (UGT1A1) FOR PATIENTS TREATED WITH IRINOTECAN Policy Number 2.02.

MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER

Bright light therapy for symptoms of anxiety and depression in focal epilepsy: randomised controlled trial

08/28/14, 08/27/15, 08/25/16, 08/25/17 CATEGORY: Therapy/Rehabilitation. Proprietary Information of Excellus Health Plan, Inc.

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

MEDICAL POLICY. SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER POLICY NUMBER: CATEGORY: Technology Assessment

University of Groningen

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

Emergency Department Boarding of Psychiatric Patients in Oregon

MEDICAL POLICY SUBJECT: PHYSICAL THERAPY (PT)

Nutrient/Nutritional Panel Testing

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6

MEDICAL POLICY SUBJECT: COMPUTER ASSISTED NAVIGATION FOR KNEE AND HIP ARTHROPLASTY

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS

Office Practice Coding Assistance - Overview

Original Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression

MEDICAL POLICY SUBJECT: TRANSPUPILLARY THERMOTHERAPY. POLICY NUMBER: CATEGORY: Technology Assessment

Use of Ambient Lighting in Creating a Healing Environment for an Inpatient Psychiatric Unit

MEDICAL POLICY EFFECTIVE DATE: 12/20/07 REVISED DATE: 12/18/08, 12/17/09, 12/16/10, 12/15/11, 12/20/12, 12/19/13

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

The Effect of Systematic Light Exposure on Sleep in a Mixed Group of Fatigued Cancer Survivors

dtb Clinical Review Management of seasonal affective disorder For the full versions of these articles see bmj.com

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

MEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS

Nutrient/Nutritional Panel Testing

MEDICAL POLICY SUBJECT: GASTRIC ELECTRICAL STIMULATION

Sleep Market Panel. Results for June 2015

MEDICAL POLICY EFFECTIVE DATE: 06/17/10 REVISED DATE: 08/18/11, 01/19/12, 12/20/12, 12/19/13, 01/22/15, 02/18/16, 03/16/17, 02/15/18

LIGHT Feeling healthy,

Transcranial Magnetic Stimulation

resources/guidelines-policies/locg.html

Seasonal Affective Disorder in Vermont

December 2014 MRC2.CORP.D.00011

BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?

MEDICAL POLICY. SUBJECT: MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES (Excluding NSCLC and CRC) EFFECTIVE DATE: 12/21/17

MEDICAL POLICY EFFECTIVE DATE: 12/20/12 REVISED DATE: 11/21/13, 10/16/14 SUBJECT: HIGH RESOLUTION ANOSCOPY

03/17/16, 03/16/17, 03/15/18 CATEGORY: Technology Assessment. Proprietary Information of Excellus Health Plan, Inc.

MEDICAL POLICY SUBJECT: HOME AND COMMUNITY OXYGEN THERAPY

Seasonal Affective Disorder 1.0 Contact Hour Presented by: CEU Professor

MEDICAL POLICY SUBJECT: PERCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION (PPTNS)

MEDICAL POLICY SUBJECT: PULMONARY REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

MEDICAL POLICY SUBJECT: MICROVOLT T-WAVE ALTERNANS

Transcription:

MEDICAL POLICY SUBJECT: PHOTOTHERAPY FOR THE ARCHIVED: 09/16/04-12/07/06 PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including an Essential Plan product, covers a specific service, medical policy criteria apply to the benefit. If a Medicare product covers a specific service, and there is no national or local Medicare coverage decision for the service, medical policy criteria apply to the benefit. POLICY STATEMENT: I. Based on our criteria and assessment of peer-reviewed literature, phototherapy for the treatment of seasonal affective disorder (SAD) using a high intensity light box (at least 10,000 lux) is considered medically appropriate for patients who meet the DSM-V criteria for a seasonal affective disorder. II. Based on our criteria and assessment of peer-reviewed literature, phototherapy for non-seasonal depression has not been proven to be medically effective and is considered investigational. III. Based on our criteria and assessment of peer-reviewed literature, use of any other light source (e.g., light visors, light caps, eyeglass clips, tanning beds) other than a high intensity light box for the treatment of SAD has not been proven to be effective and is considered investigational. Refer to Corporate Medical Policy #11.01.03 regarding Experimental and Investigational Services. POLICY GUIDELINES: Light therapy boxes are considered durable medical equipment, therefore a durable medical equipment rider/coverage is required. DESCRIPTION: Seasonal Affective Disorder (SAD) is a condition characterized by recurrent fall and winter depressions alternating with non-depressed periods in spring and summer. The cardinal clinical criteria for SAD are: I. History of at least one episode of major depression as defined by Research Diagnostic Criteria; II. Recurrent fall-winter depressions at least two of which occurred during successive years, separated by nondepressed periods in spring and summer; and III. No other DSM-V Axis I psychopathology. SAD is associated with decreases in ambient light exposure during the winter season. Phototherapy, the delivery of supplemental bright white light by a light box or a head-mounted light visor unit, has been proposed as a treatment for SAD. RATIONALE: Recent studies investigating light therapy have demonstrated that bright light therapy has shown to have a beneficial effect for patients with SAD. A meta-analysis by RN Golden, et al. (2005) concluded that bright light therapy treatment is efficacious with effect sizes equivalent to those in most antidepressant pharmacotherapy trials. A Cochrane review (A Tuunainen, et al. 2004) investigating light therapy for patients suffering from non-seasonal depression concluded that light therapy offers modest though promising antidepressive efficacy, especially when administered during the first week of treatment, in the morning, and as an adjunctive treatment to sleep deprivation responders. Due to limited data and heterogeneity of studies these results need to be interpreted with caution. A nonprofit independent licensee of the Blue Cross Blue Shield Association

PAGE: 2 OF: 5 There is insufficient evidence to support the use of light therapy for SAD when delivered by devices other than high intensity light boxes. CODES: Number Description Eligibility for reimbursement is based upon the benefits set forth in the member s subscriber contract. CODES MAY NOT BE COVERED UNDER ALL CIRCUMSTANCES. PLEASE READ THE POLICY AND GUIDELINES STATEMENTS CAREFULLY. Codes may not be all inclusive as the AMA and CMS code updates may occur more frequently than policy updates. CPT: No specific code(s) Copyright 2017 American Medical Association, Chicago, IL HCPCS: E0203 Therapeutic light box, minimum 10,000 lux, table top model A4634 Replacement bulb for therapeutic light box, table top model ICD9: 296.2 Major depressive disorder, single episode 296.3 Major depressive order, recurrent 296.90 Unspecified affective disorder 296.70 Bipolar affective disorder 300.4 neurotic depression 301.1 Affective personality disorder 311 Depression, NOS ICD10: F31.1 Bipolar disorder, current episode hypomanic REFERENCES: F31.3- F31.31 F31.4-F31.5 F31.6-F31.64 F31.70-F31.72 F31.75-F31.78 Bipolar disorder, current episode depressed, mild or moderate severity (code range) Bipolar disorder, current episode depressed, with/without psychotic symptoms (code range) Bipolar disorder, current episode mixed (code range) Bipolar disorder, full/partial remission, hypomanic/ depressed/mixed (code range) F31.9 Bipolar disorder, unspecified F32.0-F32.9 F33.0-F33.9 F34.0-F39 Major depressive disorder, single episode (code range) Major depressive disorder, recurrent (code range) Mood (affective) disorders (code range) F60.89 Other specific personality disorders American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder 2 nd edition. [http://www.psych.org/mainmenu/psychiatricpractice/practiceguidelines_1.aspx] accessed 9/18/15.

PAGE: 3 OF: 5 *Anderson JL, et al. Lux vs wavelength in light treatment of Seasonal Affective Disorder. Acta Psychiatr Scand 2009 Sep;120(3):203-12. *Avery DH, et al. Dawn stimulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry 2001 Aug 1;50(3):205-16. Baxendale S, et al. Bright light therapy for symptoms of anxiety and depression in focal epilepsy: randomized controlled trial. Br J Psychiatry 2013 May;202(5):352-6. *Benedetti F, et al. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry 2003 Jun;64(6):648-53. *BlueCross BlueShield Association. Phototherapy light for the treatment of seasonal affective and other depressive disorders. Medical Policy Reference Manual Policy #1.01.04. 2005 Jun 27. Archived Feb 2011. *BlueCross BlueShield Association Technology Evaluation Center (TEC). Phototherapy for the treatment of seasonal affective disorder.1999 May;14(12). *Bossini L, et al. Light therapy as a treatment for sexual dysfunctions. Psychother Psychosom 2009;78(2):127-8. Cheung A, et al. Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine. Depress Res Treat 2012;2012:628434. Crowley SK, et al. Efficacy of light therapy for perinatal depression: a review. J Physiol Anthropol 2012 Jun 6;31:15. Dauphinais DR, et al. Controlled trial of safety and efficacy of bright light therapy vs negative air ions in patients with bipolar depression. Psychiatry Res 2012 Mar 30;196(1):57-61. *Desan PH, et al. A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD). BMC Psychiatry 2007 Aug 7. Flory R, et al. A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of Seasonal Affective Disorder. Psychiatry Res 2010 May 15;177(1-2):101-8. *Forbes D, et al. Light therapy for managing cognitive, sleep, functional, behavioral, or psychiatric disturbances in dementia. Cochrane Database Syst Rev 2009 Oct 7;4:CD003946. Freeman MP, et al. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry 2010 Jun;71(6):669-81. *Goel N, et al. Controlled trial of bright light and negative air ions for chronic depression. Psychol Med 2005 Jul;35(7):945-55. Gordijn MC, et al. The effects of blue-enriched light treatment compared to standard light treatment in Seasonal Affective Disorder. J Affect Disord 2012 Jan;136(1-2):72-80. *Health Technology Advisory Committee (HTAC). Light therapy for seasonal affective disorder (SAD). 2001 [http://www.health.state.mn.us/htac/sad.htm] accessed 9/19/14. Hsu ZY, et al. The influence of light administration on interpersonal behavior and affect in people with mild to moderate seasonality. Prog Neuropsychopharmacol Biol Psychiatry 2014 Jan 3;48:92-101. *Institute for Clinical Systems Improvement. Health Care Guideline. Major depression in adults in primary care. 2009 May [http//www.icsi.org] accessed 9/22/15. Janas-Kozik M, et al. Bright light treatment of depressive symptoms in patients with restrictive type of anorexia nervosa. J Affect Disord 2011 May;130(3):462-5.

PAGE: 4 OF: 5 Jurvelin H, et al. Transcranial bright light treatment via the ear canals in seasonal affective disorder: a randomized, double-blind dose-response study. BMC Psychiatry 2014 Oct 21;14:288. Knapen SE, et al. The duration of light treatment and therapy outcome in seasonal affective disorder. J Affect Disord 2014 Sep;166:343-6. *Koorengevel KM, et al. Extraocular light therapy in winter depression: a double-blind placebo-controlled study. Biol Psychiat 2001 Nov 1;50(9):691-8. *Lam RW, et al. Effects of light therapy on suicidal ideation in patients with winter depression. J Clin Psychiatry 2000 Jan;61(1):30-2. *Lam RW, et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 2006 May;163(5):805-12. Lande RG, et al. Effectiveness of light therapy for depression among active duty service members: A randomized controlled pilot trial. Complement Ther Med 2011 Jun;19(3):161-3. Leichtfried V, et al. Short-term effects of bright light therapy in adults with chronic nonspecific back pain: a randomized controlled trial. Pain Med 2014 Dec;15(12):2003-12. Lieverse R, et al. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry 2011 Jan;68(1):61-70. *Leppamaki SJ, et al. Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. J Clin Psychiat 2002 Apr;63(4):316-21. *Levitt AJ, et al. A comparison of open treatment of seasonal major and minor depression with light therapy. J Affective Disord 2002 Sep;71(1-3):243-8. *Loving RT, et al. Bright light treatment of depression for older adults[isrctn55452501]. BMC Psychiatry 2005 Nov 9;5:41. Meesters Y, et al. Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating SAD. A randomized controlled trial. BMC Psychiatry 2011 Jan 28;11:17. *Michalak EE, et al. A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Res 2007 Jan 15;149(1-3):315-20. Naus T, et al. Is there a difference in clinical efficacy of bright light therapy for different types of depression? A pilot study. J Affect Disord 2013 Dec;151(3):1135-1137. Pail G, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011;64(3):152-62. *Rastad C, et al. Light room therapy effective in mild forms of seasonal affective disorder- a randomized controlled study. J Affect Disord 2008 Jun;108(3):291-6. *Ravindran AV, et al. Canadian network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord 2009 Oct;117 Suppl 1:S54-64. Reeves GM, et al. Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. J Nerv Ment Dis 2012 Jan;200(1):51-5. Roecklein KA, et al. Cognitive and behavioral predictors of light therapy use. PLoS One 2012;7(6):e39275. *Rohan KJ, et al. A randomized controlled trial of cognitive-behavioral therapy, light therapy and their combination for seasonal affective disorder. J Consult Clin Psychol 2007 Jun;75(3):489-500.

PAGE: 5 OF: 5 *Sher L, et al. Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder. J Physiatry Neuroscience 2001;26(4):336-8. Sitnikov L, et al. Cognitive predictors and moderators of winter depression treatment outcomes in cognitive-behavioral therapy vs light therapy. Behave Res Ther 2013 Dec;51(12):872-81. *Sondergaard MP, et al. Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomized, double-blind pilot study. Psychother Psychosom 2006 Jun;75(4):244-8. Strong RE, et al. Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms. Depress Anxiety 2009;26(3):273-8. *Sumaya IC, et al. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study. J Gerontol A Biol Sci Med Sci 2001 Jun;56(6):M356-60. *Terman M, et al. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005 Aug;10(8):647-63. *Terman M, et al. Controlled trial of naturalistic dawn stimulation and negative air ionization for seasonal affective disorder. Am J Psychiatry 2006 Dec;163(12):2126-33. *Tuunainen A, et al. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004;(2):CD004050, updated 2006. *Wileman SM, et al. Light therapy for seasonal affective disorder in primary care: randomized controlled trial. Br J Psychiat 2001 Apr;178:311-6. *Winkler D, et al. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry 2005 Aug 15;58 (4):331-36. Youngstedt SD, et al. Bright light treatment for high-anxious young adults: a randomized controlled pilot study. Depress Anxiety 2011 Apr;28(4):324-32. * Key article KEY WORDS: Light therapy, Phototherapy, SAD, Seasonal affective disorder. CMS COVERAGE FOR MEDICARE PRODUCT MEMBERS Based on our review, there is no specific regional or national coverage determination addressing phototherapy light devices for the treatment of depression.